Market Overview

Quanterix to Release Second Quarter 2018 Financial Results and Host Conference Call on Wednesday, August 8, 2018

Share:

Quanterix
Corporation (NASDAQ:
QTRX), a company digitizing biomarker analysis
with the goal of advancing the science of precision health, today
announced that it will release its financial results for second quarter
2018 after the close of trading on Wednesday, August 8, 2018. Company
management will host a conference call at 4:30 p.m. ET to discuss
Quanterix' financial results and provide a business update. The call
will be hosted by Kevin Hrusovsky, Chief Executive Officer, President
and Chairman, Quanterix.

Individuals interested in listening to the conference call may do so by
dialing (833) 686-9351 for domestic callers, or (612) 979-9890 for
international callers. Please reference the following conference ID:
4299369. A live webcast will be accessible on the investor relations
section of Quanterix' website: http://www.quanterix.com.
The webcast will be available on the Company's website for one year
following completion of the call.

About Quanterix

Quanterix is a company that's digitizing biomarker analysis with the
goal of advancing the science of precision health. The company's digital
health solution, Simoa, has the potential to change the way in which
healthcare is provided today by giving researchers the ability to
closely examine the continuum from health to disease. Quanterix'
technology is designed to enable much earlier disease detection, better
prognoses and enhanced treatment methods to improve the quality of life
and longevity of the population for generations to come. The technology
is currently being used for research applications in several therapeutic
areas, including oncology, neurology, cardiology, inflammation and
infectious disease. The company was established in 2007 and is located
in Lexington, Massachusetts. For additional Information, please visit https://www.quanterix.com.

Forward-Looking Statements

This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. Words
such as "may," "will," "expect," "plan," "anticipate," "estimate,"
"intend" and similar expressions (as well as other words or expressions
referencing future events, conditions or circumstances) are intended to
identify forward-looking statements. Forward-looking statements in this
news release include, but are not limited to Simoa's potential ability
to change the way in which healthcare is provided today, and are based
on Quanterix's expectations and assumptions as of the date of this press
release. Each of these forward-looking statements involves risks and
uncertainties. Factors that may cause Quanterix's actual results to
differ from those expressed or implied in the forward-looking statements
in this press release are discussed in Quanterix's filings with the U.S.
Securities and Exchange Commission, including the "Risk Factors"
sections contained therein. Except as required by law, Quanterix assumes
no obligation to update any forward-looking statements contained herein
to reflect any change in expectations, even as new information becomes
available.

View Comments and Join the Discussion!